Pharmaceutical Supply – Bupivacaine with Epinephrine Injections

The contract pertains to the supply and delivery of 1.8 mL cartridge units of Bupivacaine 0.500% w/v with Epinephrine 0.005 mg/mL (1:200,000), packaged in lots of 50 units, for use by a U.S. Navy submarine unit operating overseas. The pharmaceutical product is intended for regional anesthesia in clinical settings aboard the vessel, where immediate access to safe and effective local anesthetics is critical for medical readiness. The cartridges must meet all applicable U.S. pharmacopeial standards and be packaged to ensure stability under prolonged maritime deployment conditions, including exposure to temperature fluctuations, humidity, and vibration. The solicitation is issued under a subcontract category by the Medical Supply Chain Pharm FSA within the Department of Defense, with a North American Industry Classification System code of 325412 for pharmaceutical preparation manufacturing. The response deadline is May 6, 2026, and the place of performance is listed as FPO, 96694, indicating delivery to a fleet post office address associated with naval operations in the Pacific region. The requirement emphasizes timely delivery to support the operational readiness of deployed personnel and adherence to stringent pharmaceutical quality and packaging standards for use in austere environments.